| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/06/2007 | US20070281022 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 12/06/2007 | US20070281021 Sustained release formulation of naltrexone |
| 12/06/2007 | US20070281020 Pharmaceutical compositions for sustained release of phenylephrine |
| 12/06/2007 | US20070281019 Phenylephrine pulsed release formulations and pharmaceutical compositions |
| 12/06/2007 | US20070281018 Sustained release formulations of opioid and nonopioid analgesics |
| 12/06/2007 | US20070281017 Sustained release oxycodone composition with acrylic polymer and metal hydroxide |
| 12/06/2007 | US20070281016 Sustained release oxycodone composition with acrylic polymer and surfactant |
| 12/06/2007 | US20070281015 Anti-acid pharmaceutical composition in powder form and process for making it |
| 12/06/2007 | US20070281014 Prednisolone salt formulations |
| 12/06/2007 | US20070281013 Prednisolone salt formulations |
| 12/06/2007 | US20070281012 Modified release formulations of a bupropion salt |
| 12/06/2007 | US20070281011 Nanoparticulate posaconazole formulations |
| 12/06/2007 | US20070281010 Compositions And Methods For Enhancing Brain Function |
| 12/06/2007 | US20070281009 N-Acetylglucosamine Tablet Disintegrating In Oral Cavity And Process For Producing The Same |
| 12/06/2007 | US20070281008 Personal lubricant compositions and kits for providing personal lubrication |
| 12/06/2007 | US20070281007 Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs |
| 12/06/2007 | US20070281006 Methods And Compositions Comprising Supramolecular Constructs |
| 12/06/2007 | US20070281005 Administering zonisamide; clearing mucus; protective patches |
| 12/06/2007 | US20070281003 Plasticizer free dissolvable material comprised of polyethylene oxide and optionally additional natural and/or synthetic polymers; accurate, consistent dosing; non-self-aggregating uniform heterogeneity; eliminating air pockets prior to and during film formation; controlled drying operation |
| 12/06/2007 | US20070281002 Low irritation antimicrobial cleaning substrate |
| 12/06/2007 | US20070281000 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof |
| 12/06/2007 | US20070280995 Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye |
| 12/06/2007 | US20070280992 Sustained delivery formulations of rapamycin compounds |
| 12/06/2007 | US20070280989 Compositions and Methods for Stem Cell Expansion and Differentiation |
| 12/06/2007 | US20070280984 Bioreactor |
| 12/06/2007 | US20070280980 Percutaneous Pharmaceutical Preparation for External Use Containing Nonsteroidal Antiinflammatory Analgesic |
| 12/06/2007 | US20070280977 Multiple Emulsion Excipient for Cosmetic Actives |
| 12/06/2007 | US20070280975 Method for Producing Maca Extract |
| 12/06/2007 | US20070280974 Temperature Sensitive State-Changing Hydrogel Composition and Method for Their Preparation |
| 12/06/2007 | US20070280973 Composite material and method of producing a composite material of this type |
| 12/06/2007 | US20070280971 Phosphodiesterase type IV (PDE4) inhibitor; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[(3,4-dimethylphenyl)methyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide; inflammatory and/or allergic diseases such as atopic dermatitis |
| 12/06/2007 | US20070280926 Sting kit apparatus and method of use |
| 12/06/2007 | US20070280924 Pharmaceutical Preparations For And Treatment Of Ocular Surface and Other Disorders |
| 12/06/2007 | US20070280891 Oleaginous pharmaceutical and cosmetic foam |
| 12/06/2007 | US20070280890 System and method for disinfecting and drying a surface |
| 12/06/2007 | US20070277393 Cabinet for automatic washing or/and drying machine and automatic washing or/and drying machine with the same |
| 12/06/2007 | DE102006043216A1 Composite material for oral administration of medicinal agent, has layers containing active ingredient, ceramic nanoparticles, silver salt, or nanoparticulate carbon modification material |
| 12/06/2007 | CA2655140A1 Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses |
| 12/06/2007 | CA2654402A1 Multiple unit pharmaceutical formulation |
| 12/06/2007 | CA2653920A1 Composition for controlling snoring, in the form of a nasal spray |
| 12/06/2007 | CA2653916A1 Nasal and buccal compositions for controlling snoring |
| 12/06/2007 | CA2653821A1 Controlled-release formulation |
| 12/06/2007 | CA2653403A1 Lipoic acid pellets |
| 12/06/2007 | CA2653369A1 Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis |
| 12/06/2007 | CA2653283A1 Compositions and methods for treating conditions of the nail unit |
| 12/06/2007 | CA2653262A1 Preparation and utility of substituted carboxylic acid compounds |
| 12/06/2007 | CA2653200A1 Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations |
| 12/06/2007 | CA2653023A1 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or sa lt thereof |
| 12/06/2007 | CA2651737A1 Barrier film-forming germicidal composition for controlling mastitis |
| 12/06/2007 | CA2651716A1 Duloxetine hydrochloride delayed release formulations |
| 12/06/2007 | CA2650833A1 Autodestructive transdermal therapeutic system |
| 12/06/2007 | CA2648987A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 12/05/2007 | EP1862470A1 Element retained in blood showing degradability selectively in tumor tissue |
| 12/05/2007 | EP1862184A1 Pharmaceutical composition |
| 12/05/2007 | EP1862183A1 Pharmaceutical composition containing hardly water soluble medicament |
| 12/05/2007 | EP1862174A1 Inhibitor for insulin polymer formation |
| 12/05/2007 | EP1862164A2 Dry powder for inhalation |
| 12/05/2007 | EP1862163A1 L-Carnitin for supression of crystallisation |
| 12/05/2007 | EP1862161A1 Injectable pharmaceutical, cosmetic compositions and/or medical devices on the basis of hyaluronic-acid |
| 12/05/2007 | EP1861427A2 Agglomerated starch compositions |
| 12/05/2007 | EP1861110A1 Antibiotic combinations for providing total solution to the treatment of infections |
| 12/05/2007 | EP1861104A2 Improved gacyclidine formulations |
| 12/05/2007 | EP1861103A1 Composition comprising ocaperidone |
| 12/05/2007 | EP1861089A1 Oral modified release formulations containing 8-prenylnaringenin for continuous estrogen support |
| 12/05/2007 | EP1861082A1 A topical composition and its uses |
| 12/05/2007 | EP1861076A2 A transdermal topical composition and its uses |
| 12/05/2007 | EP1861075A2 Coated granular formulations |
| 12/05/2007 | EP1861074A1 Taste masked dosage form containing roflumilast |
| 12/05/2007 | EP1861073A2 Process for the production of calcium compositions in a continuous fluid bed |
| 12/05/2007 | EP1861072A2 Nanocells for diagnosis and treatment of diseases and disorders |
| 12/05/2007 | EP1861070A2 Drugs with improved hydrophobicity for incorporation in medical devices |
| 12/05/2007 | EP1861069A1 Contact lens, method for producing same, and pack for storage and maintenance of a contact lens |
| 12/05/2007 | EP1861054A1 Methods of manufacturing a medicated tampon assembly |
| 12/05/2007 | EP1684794A4 Altering animal waste composition |
| 12/05/2007 | EP1608335B1 Controlled release system containing saccharose acetate isobutyrate |
| 12/05/2007 | EP1594478B1 Chewing gum in the form of multi-layer tablets |
| 12/05/2007 | EP1594472B1 Delivery of a nsaid from embolic agents |
| 12/05/2007 | EP1539196B1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 12/05/2007 | EP1438025B1 Method for production of active ingredient-containing pellets |
| 12/05/2007 | EP1429722B1 Spraying method for producing powder formulations |
| 12/05/2007 | EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/05/2007 | EP1381393B1 Microparticle protection of therapeutic agents |
| 12/05/2007 | EP1339440B1 An implantable or insertable therapeutic agent delivery device |
| 12/05/2007 | EP1337284B1 Switchable tackiness coating compositions for ophthalmic implants |
| 12/05/2007 | EP1330465B1 Derivatised carbohydrates and their use in solid delivery systems |
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | EP1282446B1 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid |
| 12/05/2007 | EP1248599B1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 12/05/2007 | EP1170006B1 Drug for alleviating migrane |
| 12/05/2007 | EP1148872B1 Stable pharmaceutical formulation comprising pravastatin or atorvastatin |
| 12/05/2007 | EP1073418B1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin |
| 12/05/2007 | EP0760675B2 Compositions comprising dna damaging agents and p53 |
| 12/05/2007 | EP0731685B2 Stable multiple x/o/y emulsion |
| 12/05/2007 | CN200984392Y Magnetic medicine plaster |
| 12/05/2007 | CN200984333Y Medical plaster for the adjuvant therapy of the acute nephritis |
| 12/05/2007 | CN200984332Y Medical plaster for treating thoracic obstruction |
| 12/05/2007 | CN101084310A Semi-soft c-class immunostimulatory oligonucleotides |
| 12/05/2007 | CN101084016A Compositions capable of facilitating penetration across a biological barrier |
| 12/05/2007 | CN101083984A Therapeutic compositions for intranasal administration of ketorolac |
| 12/05/2007 | CN101083981A Flavonoid composition for treating oral diseases |